Switching from an originator biologic to a biosimilar is safe for most patients with stable inflammatory conditions. Clinical data shows no meaningful difference in effectiveness or safety, though psychological factors can lead to unnecessary discontinuation.
Find My Articles
InHousePharmacy.Vu: Your Comprehensive Guide to Medications and Supplements